Emyria Depression Program Shows Positive Results
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Emyria Ltd has released positive early results from its depression treatment program, indicating significant improvements in patients with treatment-resistant depression. The findings show that patients experienced clinically significant reductions in depression symptoms and improvements in quality of life. The results will be presented at the International Mental Health Conference, highlighting the program's potential impact on a major unmet need in mental health.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Emyria
- Emyria Confirms NSW Workforce Ahead of Clinic Opening
- Emyria Company Update Presentation
- TGA Update to Accelerate Empax Therapist Recruitment
- Emyria Activates First Victorian Empax Clinic
- March Quarter Investor Video Presentation
Later from Emyria
- June 2026 Quarterly Activities Report and Appendix 4C
- Emyria Unlocks Treatment Capacity
- Appendix 4E & Annual Financial Report Year End 30 June 2026
- Emyria Set to Launch First NSW Clinic
- FDA Selects EMD to Present at Psychedelic Medicines Hearing
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria